2020 annual financial data

Cellectar Biosciences, Inc. 2020 Operating margin

Cellectar Biosciences, Inc. 2020 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -15,290,349 USD and net income was -15,094,172 USD.
Operating cash flow was -13,932,743 USD.

Get free Cellectar Biosciences, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-15,290,349 USD
Net income
-15,094,172 USD
Operating cash flow
-13,932,743 USD